![](https://cdn.prod.website-files.com/5e59155a5c384fbe6fd867bd/60dce5ec96deee14a0f4ca6d_LCR%20-%20Logo.png)
July 2021 Newsletter
LCRC Faculty Advancing Research and Therapies
Inflammation, Obesity Increases Risk of Cancer
![](https://cdn.prod.website-files.com/5e59155a5c384fbe6fd867bd/60f1f31e2b150c9740b8eda9_d5819c4d-63dc-203c-1f11-bb177a637756.png)
Researchers at LSU Health New Orleans found a link between chronic inflammation, obesity, and an increased risk of cancer. The study was published in the June 2021 edition of Obesity. Read more.
Targeted Radiation, Prostate Cancer Treatment Breakthrough
![](https://cdn.prod.website-files.com/5e59155a5c384fbe6fd867bd/60f1f31e8200af20310323e3_820b6b65-e938-360a-61e5-7b92402f9afb.png)
Tulane Cancer Center Medical Director and LCRC Board Member Dr. Oliver Sartor was quoted in the New York Times about his work on a promising new prostate cancer therapy. It uses engineered radioactive molecules to target cancer cells in patients with advanced prostate cancer. Read more.
Collaborator Spotlight: Li Li, MD, PhD
![](https://cdn.prod.website-files.com/5e59155a5c384fbe6fd867bd/60f1f31e3d85352f605c87e7_4daca926-e886-a1e6-d5b5-99636e306e34.png)
How can doctors determine which treatments will be most effective for treating an individual patient? Li Li, MD, PhD, at Ochsner Health and a member of the LCRC faculty, helps oncologists do that. She works to bridge the gap from the lab to the bedside as oncologists seek treatment approaches tailored to a patient’s specific tumor burden and immune system. Read more.